Wells Fargo & Company Kura Oncology, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 23,562 shares of KURA stock, worth $254,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,562
Previous 24,443 3.6%
Holding current value
$254,469
Previous $503,000 8.55%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$18.57 - $23.23 $16,360 - $20,465
-881 Reduced 3.6%
23,562 $460,000
Q2 2024

Aug 13, 2024
SELL
$17.53 - $22.98 $31,624 - $41,455
-1,804 Reduced 6.87%
24,443 $503,000
Q1 2024

May 10, 2024
BUY
$13.42 - $23.53 $35,643 - $62,495
2,656 Added 11.26%
26,247 $559,000
Q4 2023

Feb 09, 2024
SELL
$7.58 - $14.38 $274,790 - $521,303
-36,252 Reduced 60.58%
23,591 $339,000
Q3 2023

Nov 13, 2023
BUY
$8.44 - $11.86 $11,697 - $16,437
1,386 Added 2.37%
59,843 $545,000
Q2 2023

Aug 15, 2023
SELL
$9.62 - $13.99 $145,973 - $212,284
-15,174 Reduced 20.61%
58,457 $618,000
Q1 2023

May 12, 2023
BUY
$10.71 - $14.6 $605,704 - $825,703
56,555 Added 331.2%
73,631 $900,000
Q4 2022

Feb 13, 2023
SELL
$11.23 - $16.9 $42,101 - $63,358
-3,749 Reduced 18.0%
17,076 $211,000
Q3 2022

Nov 14, 2022
SELL
$12.01 - $19.45 $12,886 - $20,869
-1,073 Reduced 4.9%
20,825 $284,000
Q2 2022

Aug 12, 2022
SELL
$10.71 - $18.33 $70,386 - $120,464
-6,572 Reduced 23.08%
21,898 $402,000
Q1 2022

May 16, 2022
SELL
$11.78 - $16.98 $225,386 - $324,878
-19,133 Reduced 40.19%
28,470 $458,000
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $110,346 - $176,717
9,030 Added 23.41%
47,603 $667,000
Q3 2021

Nov 15, 2021
SELL
$15.42 - $21.72 $50,161 - $70,655
-3,253 Reduced 7.78%
38,573 $722,000
Q2 2021

Aug 16, 2021
SELL
$20.85 - $29.88 $1.34 Million - $1.92 Million
-64,367 Reduced 60.61%
41,826 $873,000
Q1 2021

May 13, 2021
SELL
$24.75 - $39.14 $1.6 Million - $2.54 Million
-64,779 Reduced 37.89%
106,193 $3 Million
Q4 2020

Feb 09, 2021
BUY
$29.0 - $41.62 $3.45 Million - $4.95 Million
118,836 Added 227.93%
170,972 $5.58 Million
Q3 2020

Nov 05, 2020
SELL
$16.3 - $30.64 $7,775 - $14,615
-477 Reduced 0.91%
52,136 $1.6 Million
Q2 2020

Aug 13, 2020
BUY
$7.95 - $18.81 $103,413 - $244,680
13,008 Added 32.84%
52,613 $858,000
Q1 2020

May 14, 2020
BUY
$6.45 - $14.04 $255,452 - $556,054
39,605 New
39,605 $394,000

Others Institutions Holding KURA

# of Institutions
185
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $722M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email